Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award
- 2020年07月09日 03:30:00
- テクノロジー
- JCN Newswire
According to Frost &Sullivan:
"The Frost &Sullivan Best Practices Awards have honoured best-in-class companies that have demonstrated excellence in their respective industries. Award recipients were identified based on in-depth interviews, analysis, and extensive secondary research conducted by Frost &Sullivan analysts and companies are typically studied on their revenues, market share, capabilities, and overall contribution to the industry to identify best practices."
Avance Clinical CEO Yvonne Lungershausen:
Commending her team of more than 100 clinical trial specialists throughout Australia and New Zealand, "We have shown, with our repeat business rate greater than 75%, that our consistent sponsor focussed culture and nimble proactive approach wins every time. This has been recognised by the research team at Frost &Sullivan and the entire Avance Clinical team are very proud.
"Australia, which has successfully managed the COVID-19 crisis, is open for business for clinical trials. This award further reinforces to the biotech community that this is an early phase specialist destination where they can turn around delayed trials. Avance Clinical are experts in facilitating fast study startup with trials typically approved and initiated in under 6 weeks."
Avance Clinical has been providing high-quality clinical research services fit for global regulatory standards to the local and international drug development industry for 20 years. Avance specialises in supporting biotech companies with their early phase clinical trials, having conducted over 150 early phase (Phase 1 &2) trials in the past 4 years, involving the treatment of 8,300 participants across 95 therapeutic indications.
According to Nidhi Jalali, Analyst Best Practices, Frost &Sullivan:
"Within Asia-Pacific's highly competitive CRO market, Avance Clinical stands out as a leader in early phase biotech clinical trials. Avance's reputation for high-quality clinical trial outcomes has attracted an impressive 74% repeat business rate, underscoring the company's position as a market leader.
Avance Clinical offers a highly responsive and proactive service for biotechs wanting rapid and innovative clinical trial solutions, with the highest level of data compliance. The company has grown quickly over the past year doubling staff numbers, with plans to further expand. Avance Clinical offers a real size match for biotechs, meaning better mission understandings and stronger customer service compared to the larger CROs."
In addition to the impressive COVID-19 management in Australia, a key factor in sponsor demand is the speed, access to high-quality sites and attractive cost of running trials in Australia including:
- The Australian Government financial rebate of up to 43.5% on clinical trial spend
- No IND required for clinical trials and streamlined regulatory processes
- Advanced medical, research and scientific community, leading investigators &KOLs, modern medical facilities
Australia's reputation for FDA compliant scientific and research excellence, its advanced healthcare, and the opportunity to access patients in a less clinical trial competitive environment further reinforces its advantage as a destination for clinical trials.
Learn about running your next study with Avance Clinical: https://www.avancecro.com/.
About the Frost &Sullivan Awards
The Frost &Sullivan 2020 Best Practices Awards have honoured best-in-class companies that have demonstrated excellence in their respective industries. Award recipients were identified based on in-depth interviews, analysis, and extensive secondary research conducted by Frost &Sullivan analysts and companies are typically studied on their revenues, market share, capabilities, and overall contribution to the industry in order to identify best practices.
With a strong overall performance, Avance Clinical earns the 2020 Asia-Pacific CRO Market Leadership Award. We also recognize that your receipt of this award is the result of many individuals (employees, customers and investors) making daily choices to believe in the organization and contribute in a meaningful way to its future.
About Avance Clinical
Australia's Avance Clinical Pty Ltd has more than 20-years of experience and is now one of Australia's leading Contract Research Organisations. Avance Clinical facilitates quality drug development by aligning people, skills, and expertise in the pursuit of drug development for a healthier world.
Avance Clinical is committed to providing high-quality clinical research services with its highly-experienced team. The collective pool of knowledge and experience at Avance Clinical continually grows through the careful selection of experts who also demonstrate passion in their chosen field.
Avance Clinical offers high-quality services in an established clinical trial ecosystem, that includes world-class Investigators and Sites able to access specialised patient groups. Other benefits include:
1. The Government R&D grant means up to 43.5% rebate on clinical trial spend
2. Telehealth pivot during COVID-19 pandemic - speed and continuity
3. Site Initiation Visit (SIV) and Study Start achieved in 5 - 6 weeks
4. No IND required for clinical trials
5. Full GMP material is not mandated for Phase I clinical trials
6. An established clinical trial environment with world-class Investigators and sites
7. Established healthy subject databases and specialised patient populations
8. Five independent Phase 1 facilities across Australia including hospital-based units for critical care
9. Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with long track records in FDA compliant research
10. Seasonal studies: Northern hemisphere Sponsors can conduct their studies year-round taking advantage of Australia's counter-flu and allergy seasons
Media Contact:
media@avancecro.com
Chris Thompson
Copyright 2020 JCN Newswire. All rights reserved. www.jcnnewswire.com
イラン副大統領「ヘリ乗組員と連絡」 ライシ師ら安否は依然不明
菅井友香「好きになったらいっぱい写真撮っちゃいます」飼い猫写真は5万枚以上
大谷翔平が「2番」復帰 ベッツは「1番遊撃」でスタメン出場
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
北村匠海「映画クレヨンしんちゃん」出演に「感動」オズワルド伊藤は畠中とのセリフ量の差に…
【データ】今永昇太デビューから9試合に先発して無敗キープ 14年田中将大を上回る日本人最長
今週 暑さの質が変わります カラッとした暑さから不快な蒸し暑さへ 熱中症に注意
マンチェスターC、プレミア史上初の4連覇達成 今季の最優秀選手フォーデンが前半に2ゴール
【日本ハム】河野竜生がサヨナラ被弾「田宮の配球に首振って投げたボール。責任は僕にある」
アーセナル逆転優勝ならず 最終戦勝利も2P届かず2位フィニッシュ フル出場冨安健洋は同点弾
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
大谷翔平が不運な判定で2度見逃し三振 「えん罪退場」で話題の球審は引き揚げる大谷にブチギレ
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
吉野家が「マスク外し強要疑惑」でプチ炎上、店員さんに聞いてみると……
マンション刺殺、被害者は19歳大学生の女性 大阪・枚方
元めちゃイケメンバーの三中元克(32)現在は何をしているのか調べてみた!
藤田ニコル「脱ぐ予定なかったのですが気づいたらノリノリで…」ヒョウ柄水着姿に大反響
3度逮捕の38歳小向美奈子「今はやってないですよね?」の直撃質問に”回答”
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
ガーシーが綾野剛のLINE公開でネット騒然「ショック」「すごいエンタメ」
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
岡本夏生(56)、1600日ぶりにブログを更新した現在が衝撃
玉置浩二の妻、青田典子(53)の現在がとんでもない事になっていると話題に
ユーチューバーもこう氏、元彼女・成海瑠奈について赤裸々告白
ヒカル、浮気相手とのLINE流出にドン引きの声「キモすぎる」「吐きそう」
元めちゃイケメンバーの三中元克(32)現在は何をしているのか調べてみた!
ガーシー、またも綾野剛の暴露写真でネット歓喜「この写真見て笑っちゃう」
完全にダマされた! 『ラヴィット!』あのちゃん“事故レベル”大暴走は『水ダウ』遠隔操作のしわざだった ネットも納得
大谷翔平が不運な判定で2度見逃し三振 「えん罪退場」で話題の球審は引き揚げる大谷にブチギレ
ガーシーが綾野剛のLINE公開でネット騒然「ショック」「すごいエンタメ」
イラン副大統領「ヘリ乗組員と連絡」 ライシ師ら安否は依然不明
菅井友香「好きになったらいっぱい写真撮っちゃいます」飼い猫写真は5万枚以上
大谷翔平が「2番」復帰 ベッツは「1番遊撃」でスタメン出場
何があった!?「エアコン」が想定外の壊れ具合!投稿者に話を聞いた
北村匠海「映画クレヨンしんちゃん」出演に「感動」オズワルド伊藤は畠中とのセリフ量の差に…
【データ】今永昇太デビューから9試合に先発して無敗キープ 14年田中将大を上回る日本人最長
今週 暑さの質が変わります カラッとした暑さから不快な蒸し暑さへ 熱中症に注意
マンチェスターC、プレミア史上初の4連覇達成 今季の最優秀選手フォーデンが前半に2ゴール
【日本ハム】河野竜生がサヨナラ被弾「田宮の配球に首振って投げたボール。責任は僕にある」
アーセナル逆転優勝ならず 最終戦勝利も2P届かず2位フィニッシュ フル出場冨安健洋は同点弾